Investor Presentaiton
A Snapshot
■ One of the largest company in the Indian formulations market worth over
Rs. 480 bn (Source: ORG IMS MAT Mar-11)
Operations in US, Europe, Japan, Latin America, Asia Pacific, Africa and
Middle East regions
International sales in generic markets contribute to >42% of revenues, with
> 55% growth in formulation exports in last 5 years
Market leader in niche Indian consumer wellness market with strong brands
■ Innovation driven - investing -6% of revenues p.a. on NME, Biological and
NDDS research and Generics development
■ Dedicated team of > 13,000 Zydans across 20 countries
Market Cap Cadila Healthcare Ltd. > Rs. 180 bn (~ $ 4 bn)
(24-Jun-11) Zydus Wellness Ltd. > Rs. 22 bn (~ $ 500 mn) (72% ownership)
■ Declared the Emerging Company of the year by 'ET Award for Corporate
Excellence 2010'View entire presentation